K27M-mutant histone-3 as a novel target for glioma immunotherapy

Mutation-specific vaccines have become increasingly important in glioma immunotherapy; however, shared neoepitopes are rare. For diffuse gliomas, a driver mutation in the gene for isocitrate dehydrogenase type-1 has been shown to produce an immunogenic epitope currently targeted in clinical trials....

Descripción completa

Detalles Bibliográficos
Autores principales: Ochs, Katharina, Ott, Martina, Bunse, Theresa, Sahm, Felix, Bunse, Lukas, Deumelandt, Katrin, Sonner, Jana K., Keil, Melanie, von Deimling, Andreas, Wick, Wolfgang, Platten, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543817/
https://www.ncbi.nlm.nih.gov/pubmed/28811969
http://dx.doi.org/10.1080/2162402X.2017.1328340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543817/
https://www.ncbi.nlm.nih.gov/pubmed/28811969
http://dx.doi.org/10.1080/2162402X.2017.1328340

Ejemplares similares